Central Garden & Pet Q1 Earnings Report
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 04 2026
0mins
Should l Buy CENT?
Source: seekingalpha
- Earnings Performance: Central Garden & Pet reported a Q1 non-GAAP EPS of $0.21, beating expectations by $0.07, indicating some resilience in profitability despite broader market challenges.
- Revenue Decline: The company’s revenue of $617 million represents a 6.0% year-over-year decline, missing estimates by $14.02 million, which reflects soft market demand impacting overall sales.
- Margin Improvement: Gross margin expanded by 110 basis points to 30.9%, up from 29.8%, primarily driven by improved productivity, suggesting effective cost management strategies in place.
- Operating Income Drop: Operating income fell to $17 million from $28 million year-over-year, with operating margin decreasing from 4.3% to 2.7%, highlighting challenges in maintaining operational efficiency amidst declining revenues.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CENT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CENT
Wall Street analysts forecast CENT stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 36.900
Low
30.00
Averages
43.33
High
50.00
Current: 36.900
Low
30.00
Averages
43.33
High
50.00
About CENT
Central Garden & Pet Company is engaged in the garden and pet industries. The Company offers a portfolio of over 60 brands, including Amdro, Aqueon, Best Bully Sticks, Cadet, C&S, Farnam, Ferry-Morse, Kaytee, Nylabone, Pennington, Sevin, Zoecon, and JustiFLY. Its segments include Pet and Garden. The Pet segment includes dog and cat supplies such as treats and chews, toys, beds and containment, grooming products, waste management and training pads; supplies for aquatics, small animals, reptiles and pet birds including toys, enclosures and habitats, bedding, food and supplements; products for equine and livestock, animal and household health and insect control products; live fish and small animals as well as outdoor cushions. The Garden segment includes lawn and garden consumables such as grass seed; vegetable, flower and herb packet seed; wild bird feed, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products, and live plants.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Three Companies for Steady Wealth Growth
- Strong Performance of Spectrum Brands: In Q1 of fiscal 2026, Spectrum Brands reported an EPS of $1.40, exceeding expectations by 84%, with revenue reaching $677 million, indicating a recovery in its global pet care segment that is expected to drive future growth.
- Expansion Plans of Central Garden & Pet: Central Garden & Pet had a solid start to fiscal 2026, with management asserting that the current stock price is undervalued, announcing a $100 million expansion of its share buyback program, reflecting confidence in future growth.
- Acquisition Strategy of Prestige Consumer Healthcare: Prestige Consumer Healthcare achieved $283.4 million in revenue in Q3 of fiscal 2026, surpassing expectations despite economic challenges, and successfully acquired eye care supplier Pillar5 Pharma, further strengthening its market position.
- Long-term Wealth Building Potential: All three companies focus on brand acquisition and integration, demonstrating robust wealth growth potential through sustained profitability and cash flow generation in uncertain market conditions.
See More
Central Garden & Pet Company Announces Upcoming Investor Conferences
- Investor Conference Participation: Central Garden & Pet Company will participate in upcoming investor conferences, showcasing its leadership in the pet and garden industries, which is expected to attract investor interest and enhance market confidence.
- Financial Performance Overview: The company anticipates net sales of $3.1 billion for fiscal 2025, demonstrating strong performance and growth potential in the market, further solidifying its industry leadership.
- Brand Diversity: Central Garden & Pet Company boasts a diversified portfolio of market-leading brands, including Amdro® and Aqueon®, which enhances brand recognition and competitive positioning among consumers.
- Sustainability Commitment: The company is dedicated to promoting home health through innovative and sustainable solutions, reflecting its commitment to environmental responsibility and enhancing brand image and consumer loyalty.
See More
CENTRAL GARDEN & PET CO RECEIVES APPROVAL TO BUY BACK UP TO $100 MILLION IN STOCK
- Central Garden & Pet Company: Authorized to purchase up to $100 million of its own stock.
- Stock Buyback Program: Aimed at enhancing shareholder value and reflects confidence in the company's future.
See More
CENTRAL GARDEN & PET REVEALS EXPANSION OF STOCK REPURCHASE PROGRAM
Central Garden & Pet Announcement: Central Garden & Pet has announced an increase in stock repurchase authorization, allowing the company to buy back more of its shares.
Purpose of Repurchase: The stock repurchase is aimed at enhancing shareholder value and reflects the company's confidence in its financial position and future growth prospects.
See More
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has announced the appointment of Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, which is expected to bring extensive leadership experience in consumer products and animal health to the company.
- Extensive Industry Background: Schwichtenberg has over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health, indicating her expertise will likely drive innovation and growth for the company.
- Strategic Value Addition: Bill Brown, Chairman of the Board, noted that Schwichtenberg's operational and executive perspective will add value to the Board, aiding the company in focusing on long-term value creation and market growth.
- Educational and Professional Credentials: Schwichtenberg holds an MBA from the University of Illinois at Chicago and has held leadership positions in various industry associations, showcasing her broad influence and leadership capabilities within the industry.
See More
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has appointed Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, aiming to leverage her extensive experience in the animal health sector to drive company growth.
- Rich Industry Experience: Schwichtenberg brings over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health until her retirement in February 2023, demonstrating her deep understanding of the company.
- Leadership Recognition: Bill Brown, Chairman of the Board, stated that Schwichtenberg's leadership experience and profound understanding of consumer products and animal health will provide crucial support for the company's focus on innovation and long-term value creation, further enhancing corporate governance.
- Outstanding Educational Background: Schwichtenberg holds an MBA from the University of Illinois at Chicago and completed the Advanced Executive Program at London Business School, showcasing her expertise in business management, which can significantly contribute to strategic decision-making within the company.
See More
Three Companies for Steady Wealth Growth
- Strong Performance of Spectrum Brands: In Q1 of fiscal 2026, Spectrum Brands reported an EPS of $1.40, exceeding expectations by 84%, with revenue reaching $677 million, indicating a recovery in its global pet care segment that is expected to drive future growth.
- Expansion Plans of Central Garden & Pet: Central Garden & Pet had a solid start to fiscal 2026, with management asserting that the current stock price is undervalued, announcing a $100 million expansion of its share buyback program, reflecting confidence in future growth.
- Acquisition Strategy of Prestige Consumer Healthcare: Prestige Consumer Healthcare achieved $283.4 million in revenue in Q3 of fiscal 2026, surpassing expectations despite economic challenges, and successfully acquired eye care supplier Pillar5 Pharma, further strengthening its market position.
- Long-term Wealth Building Potential: All three companies focus on brand acquisition and integration, demonstrating robust wealth growth potential through sustained profitability and cash flow generation in uncertain market conditions.
See More
Central Garden & Pet Company Announces Upcoming Investor Conferences
- Investor Conference Participation: Central Garden & Pet Company will participate in upcoming investor conferences, showcasing its leadership in the pet and garden industries, which is expected to attract investor interest and enhance market confidence.
- Financial Performance Overview: The company anticipates net sales of $3.1 billion for fiscal 2025, demonstrating strong performance and growth potential in the market, further solidifying its industry leadership.
- Brand Diversity: Central Garden & Pet Company boasts a diversified portfolio of market-leading brands, including Amdro® and Aqueon®, which enhances brand recognition and competitive positioning among consumers.
- Sustainability Commitment: The company is dedicated to promoting home health through innovative and sustainable solutions, reflecting its commitment to environmental responsibility and enhancing brand image and consumer loyalty.
See More
CENTRAL GARDEN & PET CO RECEIVES APPROVAL TO BUY BACK UP TO $100 MILLION IN STOCK
- Central Garden & Pet Company: Authorized to purchase up to $100 million of its own stock.
- Stock Buyback Program: Aimed at enhancing shareholder value and reflects confidence in the company's future.
See More
CENTRAL GARDEN & PET REVEALS EXPANSION OF STOCK REPURCHASE PROGRAM
Central Garden & Pet Announcement: Central Garden & Pet has announced an increase in stock repurchase authorization, allowing the company to buy back more of its shares.
Purpose of Repurchase: The stock repurchase is aimed at enhancing shareholder value and reflects the company's confidence in its financial position and future growth prospects.
See More
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has announced the appointment of Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, which is expected to bring extensive leadership experience in consumer products and animal health to the company.
- Extensive Industry Background: Schwichtenberg has over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health, indicating her expertise will likely drive innovation and growth for the company.
- Strategic Value Addition: Bill Brown, Chairman of the Board, noted that Schwichtenberg's operational and executive perspective will add value to the Board, aiding the company in focusing on long-term value creation and market growth.
- Educational and Professional Credentials: Schwichtenberg holds an MBA from the University of Illinois at Chicago and has held leadership positions in various industry associations, showcasing her broad influence and leadership capabilities within the industry.
See More
Central Garden & Pet Appoints New Board Member
- New Board Appointment: Central Garden & Pet Company has appointed Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, aiming to leverage her extensive experience in the animal health sector to drive company growth.
- Rich Industry Experience: Schwichtenberg brings over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health until her retirement in February 2023, demonstrating her deep understanding of the company.
- Leadership Recognition: Bill Brown, Chairman of the Board, stated that Schwichtenberg's leadership experience and profound understanding of consumer products and animal health will provide crucial support for the company's focus on innovation and long-term value creation, further enhancing corporate governance.
- Outstanding Educational Background: Schwichtenberg holds an MBA from the University of Illinois at Chicago and completed the Advanced Executive Program at London Business School, showcasing her expertise in business management, which can significantly contribute to strategic decision-making within the company.
See More
